Medical News Today: What to know about reactive lymph nodes
Reactive lymph nodes occur when nodes swell in the body, usually due to infection or injury. Symptoms include swelling, fever, and tenderness. Treatment depends on the cause. Learn more here.
Publication date: Available online 23 April 2019Source: Revista Española de Medicina Nuclear e Imagen Molecular (English Edition)Author(s): Marco Maccauro, Giuseppe Villa, Augusto Manzara, Giulia Anna Follacchio, Gianpiero Manca, Girolamo Tartaglione, Sotirios Chondrogiannis, Lucio Mango, Domenico RubelloAbstractLymphoscintigraphy represents the “gold standard” for diagnosis of lymphedema, but an important limitation is the lack of procedural standardization. The aim of this Italian expert panel was to provide a procedural standard for lymphoscintigraphy in the evaluation of lymphatic system disorders. T...
Lymphatic filariasis (LF) is a mosquito-borne parasitic disease and a major cause of disability worldwide. To effectively plan morbidity management programmes, it is important to estimate disease burden and ev...
Lymphatic Research and Biology,Volume 17, Issue 2, Page 253-253, April 2019.
Abstract Breast cancer-related lymphedema (BCRL) is a potentially debilitating and often irreversible complication of breast cancer treatment. Risk of BCRL is proportional to the extent of axillary surgery and radiation. Other risk factors include obesity and infections. Given the 5-year survival rate of 90% and its potential impact on the quality of life of survivors of breast cancer, BCRL has become a significant financial burden on the health care system. Minimizing axillary surgery and radiation has been proven to reduce the risk of BCRL. Comprehensive multidisciplinary assessment at the time of initial diagno...
Wounds represent a significant cause of morbidity for people who inject drugs (PWID). Injecting drugs may lead to adverse cutaneous effects, such as venous sclerosis, thrombophlebitis, lymphedema, chronic venous insufficiency, and ulcers. However, epidemiological trends in PWID with wounds have not been well described. The aim of this study was to investigate the differences between PWID with and without wounds. The study was conducted within a community-based population of PWID frequenting the Infectious Disease Elimination Act (IDEA) needle exchange clinic.
Primary Lymphedema (PL) is an incurable, disfiguring, and often debilitating disease. It develops due to abnormalities in the formation and/or function of the lymphatic system and results in the accumulation of protein-rich fluid (lymph) in the interstitial space and swelling. Onset can vary from embryonic stages to middle age. Left untreated, lymphedema can lead to chronic and disabling infections and inflammation. Here, we present a new pathway that may identify novel targets for treatment of PL.
The current clinical methods for the evaluation of lymphatic vessel function, important for the early diagnosis of several pathological conditions, in particular of post-surgical lymphedema, and for the evaluation of treatment efficacy, are based on complex and mainly qualitative imaging techniques. We established a simple strategy for the painless and quantitative assessment of cutaneous lymphatic function by developing a lymphatic-specific tracer formulation that consists of the clinically approved near-infrared fluorescent dye indocyanine green and the solubilizing surfactant Kolliphor HS15.
Conclusion: Our results revealed that home-based modified CDT is more effective in reducing extremity edema volume in secondary LEL than primary LEL. It should be an available method for self-management of LEL at all stages. PMID: 30997976 [PubMed - as supplied by publisher]
Conditions: Lymphedema of Limb; Sentinel Lymph Node Interventions: Other: Early lymphedema detection; Other: Usual follow-up Sponsor: Hospital Donostia Completed
Lymphatic Research and Biology,Volume 17, Issue 2, Page 119-120, April 2019.